10114168Multi-site prospective evaluation of AI-driven tool to accelerate Breast cancer diagnosis and treatmentClosedCollaborative R&DInnovate UKThis project focuses on real-world testing of an AI-tool which informs the diagnosis and treatment of breast cancers in minutes, without the need for wet lab based tests. Currently, treatment decision-making for cancers requires several molecular tests subsequent to the confirmatory diagnosis of cancer by a pathologist. With increasing breast cancer incidence, increasing number of wet-lab test and an ageing pathologist workforce, there is a need for solutions capable of relieving workload pressures in a cost- and time-effective way. The 18-month project, which has the firm backing of a specialist patient advocacy group, aims to evaluate Panakeia's diagnostic solution to aid NHS breast cancer services by reducing pathology workloads, streamlining diagnostic workflows, shortening turnaround times and reducing costs.